글로벌 제약 플라스틱 병 시장 규모, 점유율 및 추세 분석 보고서 – 산업 개요 및 2031년까지의 예측

제약용 플라스틱 병 시장 분석

제약 플라스틱 병 시장 성장은 생산 방법 및 기술의 발전에 의해 주도됩니다. 사출 블로우 성형(IBM) 및 압출 블로우 성형(EBM)이 점점 더 많이 사용되어 우수한 품질 관리로 복잡한 병 모양을 제조하는 데 높은 정밀도를 제공합니다. 이러한 방법은 병의 차단 특성을 향상시켜 약물 효능을 유지하는 데 중요한 습기 및 오염에 더 강합니다. 또한 폴리에틸렌 테레프탈레이트 (PET) 및 고밀도 폴리에틸렌 (HDPE)과 같은 폴리머 기술의 혁신으로 인해 재료 낭비를 줄이고 생산 비용을 낮추는 더 가볍고 내구성 있는 병이 탄생하고 있습니다.

디지털 인쇄 및 라벨링 시스템의 기술적 발전은 또한 제약 병의 빠른 맞춤화를 용이하게 하여 RFID 태그와 스마트 패키징을 통해 더 나은 제품 추적 및 추적 가능성을 보장합니다. 더욱이 생분해성 플라스틱과 재활용 소재의 통합은 의료 패키징의 지속 가능성에 대한 증가하는 수요에 대응합니다.

의료 수요가 확대됨에 따라, 특히 인구 고령화와 약물 소비 증가로 인해 제약용 플라스틱 병 시장은 지속적인 성장을 보일 것으로 예상됩니다. 이러한 혁신은 효율성을 개선하고, 환경적 영향을 줄이며, 규제 요구 사항을 충족시켜 시장을 꾸준한 확장으로 자리매김합니다.

제약용 플라스틱 병 시장 규모

글로벌 제약용 플라스틱 병 시장 규모는 2023년에 81억 2천만 달러로 평가되었으며, 2031년까지 125억 6천만 달러에 도달할 것으로 예상되며, 2024년에서 2031년까지의 예측 기간 동안 CAGR은 5.60%입니다. Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 세분화, 지리적 범위, 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 수입 수출 분석, 생산 능력 개요, 생산 소비 분석, 가격 추세 분석, 기후 변화 시나리오, 공급망 분석, 가치 사슬 분석, 원자재/소모품 개요, 공급업체 선택 기준, PESTLE 분석, Porter 분석 및 규제 프레임워크가 포함됩니다.

제약 플라스틱 병 시장 동향

“지속 가능한 포장에 대한 수요 증가”

제약용 플라스틱 병 시장의 성장을 주도하는 특정 추세 중 하나는 지속 가능한 포장에 대한 수요 증가입니다. 환경 문제가 커지면서 제약 회사는 병에 재활용 가능하고 생분해성 플라스틱과 같은 친환경 소재로 전환하고 있습니다. 예를 들어, 2024년 1월 Bormioli Pharma와 Loop Industries는 Pharmapack Europe 2024에서 혁신적인 제약용 포장 솔루션을 공개했습니다. 새롭게 디자인된 병은 100% 재활용된 순수 품질의 Loop PET 수지를 사용하여 제조되었으며, 이는 지속 가능한 포장의 상당한 진전을 나타냅니다. 이 이니셔티브는 제약 산업에서 환경 친화적 소재에 대한 수요가 증가하고 있는 것과 일치하며, 두 회사의 지속 가능성과 책임 있는 조달에 대한 헌신을 보여줍니다.

보고서 범위 및 제약 플라스틱 병 시장 세분화         

Pharmaceutical Plastic Bottle Market Definition

Pharmaceutical plastic bottles are specialized containers used for storing and packaging medications in liquid, solid, or powder form. Made from high-quality, non-reactive plastic materials such as polyethylene, polypropylene, or polyethylene terephthalate (PET), these bottles ensure the safe containment of pharmaceutical products. They provide protection against contamination, moisture, and light, preserving the integrity of medications. The bottles are designed to meet stringent regulatory standards, featuring child-resistant caps, tamper-evident seals, and accurate dosage markings. Their lightweight nature, durability, and resistance to breakage make them an essential component in the distribution and storage of both prescription and over-the-counter medications.

Pharmaceutical Plastic Bottle Market Dynamics

Drivers

• Increasing Demand for Lightweight Packaging

The pharmaceutical plastic bottle market is driven by the increasing demand for lightweight packaging. Plastic bottles are preferred over traditional glass containers due to their significantly lower weight, which reduces shipping costs and the risk of breakage during transport. This is especially important for pharmaceutical companies distributing products globally. For instance, Pfizer's switch to plastic bottles for certain medications led to lower logistics costs and enhanced product safety during long-distance shipping. The lightweight nature of plastic bottles also makes them more convenient for consumers, who can easily carry and store medications, further supporting market growth in both prescription and OTC packaging.

• Increased Demand for OTC Medications

The rising popularity of over-the-counter (OTC) medications is significantly driving the growth of the pharmaceutical plastic bottle market. Consumers increasingly prefer OTC drugs for treating common ailments, due to convenience and cost savings. Plastic bottles provide an ideal packaging solution for these medications, as they are lightweight, durable, and easy to transport. For instance, pain relievers such as ibuprofen and acetaminophen, available without prescription, are commonly packaged in plastic bottles. This surge in OTC drug sales has increased the demand for plastic packaging, as it ensures portability and long shelf life, further boosting the growth of the pharmaceutical plastic bottle market.

Opportunities

• Advancements in Plastic Technologies

Recent technological advancements in plastic materials have significantly impacted the pharmaceutical plastic bottle market. Innovations such as the development of high-barrier plastics, such as ethylene vinyl alcohol (EVOH), provide superior protection against moisture and oxygen, enhancing product safety and shelf life. Additionally, eco-friendly materials, including bioplastics made from renewable resources, are gaining traction. For instance, in February 2023, Berry Global Healthcare launched a comprehensive solution package targeting the growing demand for child-resistant (CRC) and tamper-evident (TE) packaging within the pharmaceutical and herbal markets. This innovative offering is particularly focused on syrup and liquid medicines, ensuring enhanced safety and compliance. By addressing customer needs for secure packaging, Berry Global reinforces its position as a leader in healthcare packaging solutions.

• Growing Pharmaceutical Industry

The expanding pharmaceutical industry significantly drives the demand for plastic bottles, creating substantial market opportunities. As global medication production increases, especially in emerging markets such as India and China, the need for efficient packaging solutions grows. For instance, in January 2023, Aptar Pharma introduced the APF Futurity, its pioneering metal-free, multidose nasal spray pump. This innovative product is designed to deliver nasal saline and comparable over-the-counter (OTC) formulations effectively. The launch of APF Futurity marks a significant advancement in drug delivery systems, catering to the increasing consumer preference for safer and more efficient nasal spray solutions in the healthcare market.

Restraints/Challenges

• High Cost of Production

The cost of production for high-quality pharmaceutical plastic bottles is a significant restraint in the market. These bottles necessitate advanced manufacturing processes, such as precise molding and sterilization techniques, which are often capital-intensive. This complexity can lead to higher production costs, making it difficult for manufacturers, particularly smaller companies, to maintain competitive pricing. As these increased costs impact profit margins, companies may struggle to invest in research, development, and marketing. Furthermore, the financial burden can limit their ability to innovate or adapt to changing market demands, ultimately hindering growth and competitiveness in the pharmaceutical packaging sector.

• Competition from Alternative Packaging

The pharmaceutical plastic bottle market faces significant competition from alternative packaging solutions such as glass and biodegradable materials. Glass offers superior barrier properties, safeguarding the integrity of sensitive medications and enhancing shelf life. Additionally, biodegradable options appeal to environmentally conscious consumers, aligning with the growing demand for sustainable practices in packaging. As regulatory pressures increase on plastic waste, manufacturers may find it challenging to compete with alternatives that promise reduced environmental impact. This shift in consumer preference towards safer and more sustainable options hinders growth in the plastic bottle market, pushing manufacturers to rethink their strategies and product offerings to maintain relevance.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an analyst brief, our team will help you take an informed market decision to achieve market growth.

Impact and Current Market Scenario of Raw Material Shortage and Shipping Delays

Data Bridge Market Research offers a high-level analysis of the market and delivers information by keeping in account the impact and current market environment of raw material shortage and shipping delays. This translates into assessing strategic possibilities, creating effective action plans, and assisting businesses in making important decisions.

Apart from the standard report, we also offer in-depth analysis of the procurement level from forecasted shipping delays, distributor mapping by region, commodity analysis, production analysis, price mapping trends, sourcing, category performance analysis, supply chain risk management solutions, advanced benchmarking, and other services for procurement and strategic support.

Expected Impact of Economic Slowdown on the Pricing and Availability of Products

When economic activity slows, industries begin to suffer. The forecasted effects of the economic downturn on the pricing and accessibility of the products are taken into account in the market insight reports and intelligence services provided by DBMR. With this, our clients can typically keep one step ahead of their competitors, project their sales and revenue, and estimate their profit and loss expenditures.

Pharmaceutical Plastic Bottle Market Scope

The market is segmented on the basis of raw materials, bottle type, closure type and capacity. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Raw Materials

• Polyethylene Terephthalate (PET)
• Poly Propylene (PP)
• Low Density Poly Ethylene (LDPE)
• High Density Poly Ethylene (HDPE)

Bottle Type

• Solid Containers
• Dropper Bottles
• Nasal Spray Bottles
• Liquid Bottles
• Oral Care
• Other

 Closure Type

• Screw Cap
• Crown Cap
• Friction Fit
• Other Closures

 Capacity

• Less Than 10 ml
• 10 – 30 ml
• 31 – 50 ml
• 51 – 100 ml
• 100 ml and Above

Pharmaceutical Plastic Bottle Market Regional Analysis

The market is analysed and market size insights and trends are provided by country, raw materials, bottle type, closure type and capacity as referenced above.

The countries covered in the market report are U.S., Canada, Mexico, Brazil, Argentina, Rest of South America, Germany, France, Italy, U.K., Belgium, Spain, Russia, Turkey, Netherlands, Switzerland, Rest of Europe, Japan, China, India, South Korea, Australia and New Zealand, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, United Arab Emirate, Saudi Arabia, Egypt, Israel, South Africa, Rest of Middle East and Africa

North America is expected to dominate the pharmaceutical plastic bottle market due to stringent regulations and increasing demand from end-user applications. The region's emphasis on safety and quality assurance drives the adoption of advanced packaging solutions. Additionally, the growth of cost-effective manufacturing processes further boosts market potential, enabling companies to meet the rising needs for sustainable and efficient pharmaceutical packaging solutions.

Asia-Pacific is expected to show significant growth in the pharmaceutical plastic bottle market due to its strong production base for PET resin and polymers. The region benefits from an abundant supply of raw materials, particularly in China, which stands out as one of the largest producers and consumers of PET bottles. This favorable environment positions Asia-Pacific as a key player in the pharmaceutical packaging sector.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Pharmaceutical Plastic Bottle Market Share

시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 애플리케이션 우세입니다. 위에 제공된 데이터 포인트는 시장과 관련된 회사의 초점에만 관련이 있습니다.

시장에서 운영되는 제약용 플라스틱 병 시장 리더는 다음과 같습니다.

• CKS 패키징(미국)
• Comar, LLC(미국)
• 암코 리미티드(호주)
• Cospack America Corp. (미국)
• 그레이엄 패키징 컴퍼니(미국)
• Sonoco Products Company (미국)
• 실드 에어(미국)
• 스머핏 카파(아일랜드)
• 플라스티팩 홀딩스(미국)
• 알파 패키징(미국)
• 베리 글로벌 주식회사(미국)
• 캐나다 컨테이너 공사(캐나다)
• Aaron Packaging, Inc. (미국)
• CCC 포장(미국)
• HOKKAN HOLDINGS LIMITED (일본)
• Gerresheimer AG(독일)
• Indorama Ventures Public Company Limited(태국)
• Mpact (남아프리카 공화국)
• PDG Plastiques(프랑스)
• 에스터폼 유한회사(영국)
• RESILUX NV(벨기에)

제약용 플라스틱 병 시장의 최신 동향

• 2024년 4월, Berry Global Group은 의료 생산 용량을 최대 30%까지 강화하는 것을 목표로 한 전략적 투자를 발표했습니다. 이 이니셔티브는 유럽의 3개 주요 사이트에서 제조 역량을 확장하는 데 중점을 두고, 의료용 포장 솔루션에 대한 수요 증가에 부응하려는 회사의 의지를 강화합니다. 이 투자는 Berry Global이 의료 분야에서 혁신과 품질에 헌신하고 있음을 강조합니다.
• 2022년 5월, Gerresheimer AG는 제약 및 의료 운영을 위한 현지 공급을 강화하기 위해 인도에서 제조 역량을 확대했습니다. 이 회사는 Kosamba 사이트에 플라스틱 용기와 마개를 생산하도록 특별히 설계된 새로운 공장을 개장했습니다. 이 개발은 Gerresheimer의 생산 능력을 향상시킬 뿐만 아니라 지역 시장 수요를 충족하기 위한 일관되고 안정적인 포장 솔루션을 제공한다는 전략적 목표를 지원합니다.
• 2021년 11월, 일본의 유명 제약 회사인 Santen Pharmaceutical Co. Ltd.는 유럽, 중동, 아프리카(EMEA) 지역에서 최초의 바이오 기반 플라스틱 눈약 병을 출시할 계획이라고 발표했습니다. 이 이니셔티브는 탄소 배출량 제로 달성에 대한 Santen의 광범위한 노력의 일환입니다. 이 친환경 포장 솔루션의 출시는 제약 산업에서 지속 가능성과 혁신에 대한 회사의 헌신을 반영합니다.

SKU-53789